New SEC Form D filing
3Helix, Inc., 2026-09-21
A new SEC Form D private-offering notice from Salt Lake City, UT, a $10,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Develops collagen hybridizing peptide (CHP) research and diagnostic tools used in histopathology, fibrosis, and cancer research
Filed 2026-09-21Filed to raise $10,000,000First money in 2026-08-31Raised so far $7,835,028HQ (as filed) Salt Lake City, UTSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified 3helix.com↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Dynagentic Inc., 2026-09-30, $3M, Salt Lake City, UT
- Typewriter Therapeutics, Inc., 2026-09-21, $56.3M, Cambridge, MA
- Future42, Inc., 2026-09-24, $250K, American Fork, UT
- Therapeutic Neuromodulation Systems LLC, 2026-09-21, $5M, Metairie, LA
- Salty AI Inc., 2026-09-22, $4.5M, Park City, UT
- Monocacy Therapeutics Inc., 2026-09-21, $49, Monrovia, MD
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.